Weight-loss drug startup Metsera wants to take on Novo and Lilly. Here's what you need to know
Related Articles
-
How weight-loss drugs are changing the diet industry
Ever since college, Brad Jobling struggled with his weight, fluctuating between a low of 155 pounds when he was in his thirties to as high as 220. He spent a decade tracking calories on WeightWatchers, but the pounds he dropped always crept back onto his 5-foot-5-inch frame. A little over a year ago, the 58-year-old Manhattan resident went on a new weight loss drug called Wegovy. He’s lost 30 pounds, and has started eating healthier food and exercising—the habits behind many commercial diet...
-
Kela eyes ballooning cost of weight loss drugs
Finland has seen a surge in demand for popular anti-obesity medications.
-
Women are reporting 'Ozempic breasts' while taking weight-loss drugs
Plastic surgeons say the rapid weight loss can also cause the breasts to sag. Ozempic users have opened up about experiencing shifts in breast size. READ MORE: Can weight loss drugs cause facial aging? Experts views